carbostyril has been researched along with Paranoia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagney, A; Caballero, M; Jiménez-Arriero, MA; Rodríguez-Jiménez, R; Torio, I | 1 |
| Christopher, EJ; Gagliardi, JP; Kahn, DA; Muzyk, AJ | 1 |
| Faludi, G; Fejes, L; Inczédy-Farkas, G; Kassai-Farkas, A; Lazáry, J; Makkos, Z | 1 |
| DeQuardo, JR | 1 |
| Goforth, HW; Rao, M; Sucholeiki, R | 1 |
| Duggal, V; Glick, ID; Hodulik, C | 1 |
| Aderhold, V; Haasen, C; Lambert, M; Reimer, J | 1 |
7 other study(ies) available for carbostyril and Paranoia
| Article | Year |
|---|---|
[Psychosis due to vitamin B12 deficiency in an elderly patient].
Topics: Aged; Antipsychotic Agents; Aripiprazole; Female; Gastritis, Atrophic; Humans; Paranoid Disorders; Piperazines; Psychological Tests; Quinolones; Remission Induction; Risperidone; Vitamin B 12; Vitamin B 12 Deficiency | 2014 |
Use of aripiprazole in a patient with multiple sclerosis presenting with paranoid psychosis.
Topics: Antipsychotic Agents; Aripiprazole; Female; Humans; Middle Aged; Multiple Sclerosis; Paranoid Disorders; Piperazines; Quinolones; Treatment Outcome | 2010 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hallucinations; Haloperidol; Humans; Hungary; Male; Marijuana Abuse; Olanzapine; Paranoid Disorders; Piperazines; Psychomotor Performance; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology | 2011 |
Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?
Topics: Anger; Antipsychotic Agents; Aripiprazole; Chronic Disease; Humans; Male; Middle Aged; Paranoid Disorders; Piperazines; Psychomotor Agitation; Quinolones; Schizophrenia | 2004 |
Chronic interictal psychosis responsive to aripiprazole.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Chronic Disease; Clonazepam; Delusions; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epilepsy, Complex Partial; Epilepsy, Temporal Lobe; Female; Humans; Lamotrigine; Paranoid Disorders; Piperazines; Quinolones; Treatment Outcome; Triazines | 2004 |
Aripiprazole as a dopamine partial agonist: positive and negative effects.
Topics: Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Female; Humans; Male; Middle Aged; Paranoid Disorders; Piperazines; Quinolones; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists | 2006 |
Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diet; Epilepsy, Generalized; Female; Hallucinations; Humans; Hypnotics and Sedatives; Hypothyroidism; Lorazepam; Magnetic Resonance Imaging; Multiple Sclerosis; Paranoid Disorders; Piperazines; Psychotic Disorders; Quinolones | 2006 |